Transforming Precision Therapies Through Robust Liquid Biopsy Testing

This Event Has Now Run

Thank you to our speakers, sponsors, and delegates who joined us in San Diego! If you are interested in the 2027 event, please get in touch at: info@hansonwade.com

Address Translational & Commercial Challenges to Seamlessly Utilize Liquid Biopsy Technologies to Drive Smarter, Accelerated Oncology Drug Development

The Liquid Biopsy for Precision Oncology Summit, is the leading annual meeting uniting pharma, biotech, diagnostics, consortia, academia and patient voices to accelerate collaboration and progress in the rapidly advancing field of liquid biopsy. 

For its 10th year, this meeting delivered unparalleled insights, data, technology updates, and strategies spanning the entire drug development pipeline - from preclinical discovery, through clinical translation, to regulatory approval, reimbursement, and commercial adoption. 

If you are working in precision oncology, or need enhanced insights into your patient population, optimized diagnostic and prognostic tools, or earlier detection of disease, this meeting should be considered a staple entry in to your future conference calendar.

Across ctDNA, MRD, multi-omic biomarkers, and novel analytes, you will see how pharma are strategically integrating liquid biopsies into therapeutic pipelines, how diagnostic companies are designing more sensitive assays, and how the field is overcoming barriers to widespread clinical adoption. 

What’s more?
Tickets were complimentary* for biopharma.

A great mix of cutting edge scientist and vendors, pharma, and clinical presentations. It was very valuable to help me keep up in this constantly updating field and both share my work and learn from others.

Past Speaker, Director – Computational Biology, Lantern Pharma

Lantern Pharma

An excellent conference. It was a good mix of topics broadly relevant to the community covered in plenary sessions, more specialized options in two parallel tracks, and easy access to exhibitors.

Past Speaker, Executive Director – Translational Medicine, Oric Pharmaceuticals

Oric Pharmaceuticals

Great opportunity to meet colleagues of the same field from other companies as well as vendors to learn about their new offerings.

Past Attendee, Director, Pfizer

Pfizer

Expertise Partners 2026

63637 - 10th Liquid Biopsy for Precision Oncology Summit (3)

Attending Companies Included

Amgen-Logo
Bristol Myers Squibb
Abbvie
GSK logo
Fore Biotherapeutics
FightCRC
Zai Lab
Tata Memorial Centre
Cardiff Oncology
Vir Bio
Janux Therapeutics
Akamis Bio
Eli Lilly
Luxvitae Therapeutics
McGill University
Menarini Stemline
Mersana Therapeutics
The National Institutes of Health 
Explore the agenda
Explore the Full Agenda

Dive into 2 tracks and 4 workshops led by 40+ expert speakers shaping the future of liquid biopsy

Partner With Us
Prioritize Partnering With Us

Showcase your solutions, connect with decision-makers, and position your company as the go-to provider in precision oncology

Join the Community
Join 250+ Biopharma Experts

Network with pharma, biotech, diagnostics, academia, consortia, and patient voices driving real-world adoption